Today: 11 June 2026
Palo Alto Networks stock jumps as Nasdaq sets a close date for the CyberArk deal
9 February 2026
2 mins read

Palo Alto Networks stock jumps as Nasdaq sets a close date for the CyberArk deal

New York, Feb 9, 2026, 2:30 PM EST — The regular session is underway.

  • Palo Alto Networks shares climbed in the afternoon, with investors zeroing in on a Nasdaq notice that detailed the CyberArk merger timeline.
  • CyberArk shares moved higher, and after-hours trading will be halted on Feb. 10 as the anticipated closing approaches.
  • Deal terms and Palo Alto’s Feb. 17 quarterly numbers are in focus, with traders looking for early signals on integration and demand.

Palo Alto Networks shares gained Monday after a Nasdaq Trader update laid out a provisional timeline for the company’s acquisition of CyberArk. The notice puts the merger’s expected closure just before the market opens on Feb. 11. CyberArk stock is set to halt trading after-hours on Feb. 10 around 7:50 p.m., with suspension following on Feb. 12. Each CyberArk shareholder stands to get $45 in cash plus 2.2005 Palo Alto shares for every CyberArk share held.

The timing is crucial here — a deal that’s been in the works suddenly becomes something traders have to act on right away. For deal-arb funds, that means jumping in around those key dates: they’ll typically buy shares of the target, short the acquirer, and try to pocket the spread. This kind of positioning can really crank up volatility for both stocks.

Investors end up pricing the stock leg with less room for error. Because CyberArk holders’ payout tracks Palo Alto’s share movements, shifts in PANW’s price can instantly alter what the deal is really worth.

Palo Alto Networks climbed 3.4% to $164.81 by the afternoon. Shares started the day at $159.34, dipping to $156.55 at one point, according to market data.

CyberArk climbed 4.0%, finishing at $407.38.

The merger calls for Palo Alto to issue fresh shares to seal the deal, a detail that’s made some investors nervous over potential dilution — more shares in the mix can drag on earnings per share. Still, some argue the combination strengthens Palo Alto’s hand in identity security, a segment right at the heart of enterprise breach risks.

Palo Alto and CyberArk unveiled their agreement back in July 2025, putting a roughly $25 billion price tag on CyberArk. The move was billed as Palo Alto’s official foray into identity security.

Beyond the deal, software stocks have been bouncing around in a volatile market. Morgan Stanley’s equity strategy head, Mike Wilson, said in a note Monday that “fundamental tailwinds remain in place for the AI enabler complex,” following last week’s pronounced swings in tech. Business Insider

But that timing isn’t set in stone. Nasdaq has described the closing as tentative. Any hang-up—whether it’s regulatory, operational, or just procedural—could rattle the spread and take a toll on both stocks. The deal consideration still tracks, in part, Palo Alto’s share price.

Investors are turning their attention to Palo Alto, which is set to report its fiscal second-quarter numbers after U.S. markets wrap up on Feb. 17. They’ll be watching for signs of shifting demand, plus any fresh details from management on how the CyberArk integration is shaping up.

Stock Market Today

  • Sigma Healthcare's Valuation Reassessed After Recent Share Price Declines
    June 11, 2026, 4:09 PM EDT. Sigma Healthcare (ASX:SIG) shares have declined 7.6% over the past week and 15.5% over the past year but exhibit strong long-term gains with a 231.7% return over three years. The stock currently trades at A$2.69, slightly below Simply Wall St's discounted cash flow (DCF) valuation of A$2.81 per share, indicating it is roughly fairly valued with a 4.1% discount. Despite short-term price weakness, Sigma Healthcare scores 2 out of 6 on valuation metrics, suggesting mixed signals on undervaluation. Its free cash flow is projected to increase substantially through 2028, supporting the fair value estimate. Investors are balancing recent price softness with long-term fundamentals amid ongoing reassessments of risk and return in Australia's healthcare supply chain sector.

Latest articles

Coeur Mining Climbs as S&P MidCap 400 Inclusion Approaches, Silver Stocks Gain

Coeur Mining Climbs as S&P MidCap 400 Inclusion Approaches, Silver Stocks Gain

11 June 2026
Coeur Mining surged 5.2% to $16.205 on heavy volume as investors positioned ahead of its S&P MidCap 400 addition effective June 22, following recent acquisitions and a sector-wide rally in precious-metals stocks; the company’s market cap hit $16.76 billion, with index inclusion and recent financial results drawing institutional attention.
Trump Media drops Truth Social spin-off, DJT holders turn to $6 bln TAE merger

Trump Media drops Truth Social spin-off, DJT holders turn to $6 bln TAE merger

11 June 2026
Trump Media, TAE Technologies and Texas Ventures Acquisition III have scrapped plans to spin off Truth Social and other media assets, keeping them within Trump Media as it pursues a merger with TAE; DJT shares traded at $8.03 Thursday after falling over 38% this year, with the next key event being the merger filing process and SEC registration.
JPMorgan (JPM) stock price jumps nearly 4% as Dow tops 50,000 — what to watch before Monday’s open
Previous Story

JPMorgan (JPM) stock price jumps nearly 4% as Dow tops 50,000 — what to watch before Monday’s open

QVC Group stock (QVCGA) plunges on creditor-talks report as bankruptcy risk comes into view
Next Story

QVC Group stock (QVCGA) plunges on creditor-talks report as bankruptcy risk comes into view

Go toTop